Physician

Alexander Banashkevich, M.D.

According to 2025 Medicare claims, Alexander Banashkevich, M.D. (NPI: 1881005007) practices radiation oncology in the Syracuse, NY market, with the plurality of this provider's patient population coming from Oswego, NY. This provider's primary affiliated billing organization is UPSTATE UNIVERSITY RADIATION ONCOLOGY, INC. (NPI: 1922337195; TIN: 010937318) and primary practice location at 13126-6667. Banashkevich is affiliated with the Humana Direct Contracting Entity, Inc. (ACO ID: D0203), participating under the REACH model.

Banashkevich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 284 traditional Medicare patients, billed 1,178 HCPCS/CPT codes, and received $79,912 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 333 prescription claims across 88 beneficiaries totaling $181,919 in drug costs, led by Orgovyx (Relugolix). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $370,437 to $79,912. In contrast, Part D prescription costs have moved sharply higher in recent years, from $2,692 to $181,919. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$193K$386K2015 Medicare payment: $370,437 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $385,876 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $343,255 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $347,021 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $152,370 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $123,291 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $116,452 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $115,926 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $126,174 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $79,912 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152212,914$370,437
20162732,926$385,876
20171982,623$343,255
20182632,894$347,021
20193282,072$152,370
20203091,671$123,291
20213201,701$116,452
20222841,522$115,926
20233161,875$126,174
20242841,178$79,912

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$147K$295K2015 Drug cost: $2,692 (USD; Tot_Drug_Cst)2016 Drug cost: $2,339 (USD; Tot_Drug_Cst)2017 Drug cost: $2,013 (USD; Tot_Drug_Cst)2018 Drug cost: $2,689 (USD; Tot_Drug_Cst)2019 Drug cost: $2,165 (USD; Tot_Drug_Cst)2020 Drug cost: $8,788 (USD; Tot_Drug_Cst)2021 Drug cost: $30,783 (USD; Tot_Drug_Cst)2022 Drug cost: $92,050 (USD; Tot_Drug_Cst)2023 Drug cost: $294,869 (USD; Tot_Drug_Cst)2024 Drug cost: $181,919 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153149$2,692
20163255$2,339
20173565$2,013
20184065$2,689
20194898$2,165
202041107$8,788
202175210$30,783
202271240$92,050
2023100408$294,869
202488333$181,919

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77427Radiation treatment management, 5 treatment sessions3599$146
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more3232$133
77263Complex radiation therapy planning3233$127
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more94142$42
77014Ct guidance for insertion of radiation therapy fields122415$34

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OrgovyxRelugolix641,910$165,374
MyrbetriqMirabegron21780$11,241
Tamsulosin HclTamsulosin Hcl14610,470$2,027
Oxybutynin Chloride ErOxybutynin Chloride311,110$443

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Alexander Banashkevich, M.D.?

Tedicare shows public-source Medicare data for Alexander Banashkevich, M.D. (NPI 1881005007), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Banashkevich, M.D. have ACO affiliation data?

Alexander Banashkevich, M.D. is shown with ACO affiliation data for Humana Direct Contracting Entity, Inc. (REACH, ACO ID D0203).

What billing organization is linked to Alexander Banashkevich, M.D.?

Alexander Banashkevich, M.D. is linked to UPSTATE UNIVERSITY RADIATION ONCOLOGY, INC. (billing NPI 1922337195) in the available physician profile data.

Does Alexander Banashkevich, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.